These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16408787)

  • 1. Identification of a pharmacophore of SKCa channel blockers.
    Dilly S; Graulich A; Farce A; Seutin V; Liegeois JF; Chavatte P
    J Enzyme Inhib Med Chem; 2005 Dec; 20(6):517-23. PubMed ID: 16408787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. bis-Quinolinium cyclophanes: 8,14-diaza-1,7(1, 4)-diquinolinacyclotetradecaphane (UCL 1848), a highly potent and selective, nonpeptidic blocker of the apamin-sensitive Ca(2+)-activated K(+) channel.
    Chen JQ; Galanakis D; Ganellin CR; Dunn PM; Jenkinson DH
    J Med Chem; 2000 Sep; 43(19):3478-81. PubMed ID: 11000001
    [No Abstract]   [Full Text] [Related]  

  • 3. Bis-quinolinium cyclophanes: 6,10-diaza-3(1,3),8(1,4)-dibenzena-1,5(1,4)- diquinolinacyclodecaphane (UCL 1684), the first nanomolar, non-peptidic blocker of the apamin-sensitive Ca(2+)-activated K+ channel.
    Rosa JC; Galanakis D; Ganellin CR; Dunn PM; Jenkinson DH
    J Med Chem; 1998 Jan; 41(1):2-5. PubMed ID: 9438015
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis, molecular modeling, and pharmacological testing of bis-quinolinium cyclophanes: potent, non-peptidic blockers of the apamin-sensitive Ca(2+)-activated K(+) channel.
    Campos Rosa J; Galanakis D; Piergentili A; Bhandari K; Ganellin CR; Dunn PM; Jenkinson DH
    J Med Chem; 2000 Feb; 43(3):420-31. PubMed ID: 10669569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bis-quinolinium cyclophanes: highly potent and selective non-peptidic blockers of the apamin-sensitive Ca2+-activated K+ channel.
    Conejo-García A; Campos JM
    Curr Med Chem; 2008; 15(13):1305-15. PubMed ID: 18537610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of small conductance calcium-activated potassium channels expressed in PVN in regulating sympathetic nerve activity and arterial blood pressure in rats.
    Gui L; LaGrange LP; Larson RA; Gu M; Zhu J; Chen QH
    Am J Physiol Regul Integr Comp Physiol; 2012 Aug; 303(3):R301-10. PubMed ID: 22647293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interactions of apamin and tetraethylammonium are differentially affected by single mutations in the pore mouth of small conductance calcium-activated potassium (SK) channels.
    Dilly S; Philippart F; Lamy C; Poncin S; Snyders D; Seutin V; Liégeois JF
    Biochem Pharmacol; 2013 Feb; 85(4):560-9. PubMed ID: 23270990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial SAR studies on apamin-displacing 2-aminothiazole blockers of calcium-activated small conductance potassium channels.
    Gentles RG; Grant-Young K; Hu S; Huang Y; Poss MA; Andres C; Fiedler T; Knox R; Lodge N; Weaver CD; Harden DG
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5316-9. PubMed ID: 18774291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric block of KCa2 channels by apamin.
    Lamy C; Goodchild SJ; Weatherall KL; Jane DE; Liégeois JF; Seutin V; Marrion NV
    J Biol Chem; 2010 Aug; 285(35):27067-27077. PubMed ID: 20562108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and pharmacological testing of polyaminoquinolines as blockers of the apamin-sensitive Ca2+-activated K+ channel (SK(Ca)).
    Fletcher DI; Ganellin CR; Piergentili A; Dunn PM; Jenkinson DH
    Bioorg Med Chem; 2007 Aug; 15(16):5457-79. PubMed ID: 17560109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crucial role of a shared extracellular loop in apamin sensitivity and maintenance of pore shape of small-conductance calcium-activated potassium (SK) channels.
    Weatherall KL; Seutin V; Liégeois JF; Marrion NV
    Proc Natl Acad Sci U S A; 2011 Nov; 108(45):18494-9. PubMed ID: 22025703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model studies of the function of blockers on the small conductance potassium ion channel.
    Ciechanowicz-Rutkowska M; Lewinski K; Oleksyn B; Stec B
    J Pept Res; 2003 Sep; 62(3):125-33. PubMed ID: 12895274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SK channel blockade reverses cognitive and motor deficits induced by nigrostriatal dopamine lesions in rats.
    Chen L; Deltheil T; Turle-Lorenzo N; Liberge M; Rosier C; Watabe I; Sreng L; Amalric M; Mourre C
    Int J Neuropsychopharmacol; 2014 Aug; 17(8):1295-306. PubMed ID: 24661728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypobaric Hypoxia-Induced Learning and Memory Impairment: Elucidating the Role of Small Conductance Ca
    Kushwah N; Jain V; Dheer A; Kumar R; Prasad D; Khan N
    Neuroscience; 2018 Sep; 388():418-429. PubMed ID: 30048783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bis-quinolinium cyclophanes: toward a pharmacophore model for the blockade of apamin-sensitive SKCa channels in sympathetic neurons.
    Galanakis D; Ganellin CR; Chen JQ; Gunasekera D; Dunn PM
    Bioorg Med Chem Lett; 2004 Aug; 14(16):4231-5. PubMed ID: 15261276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. K+ currents generated by NMDA receptor activation in rat hippocampal pyramidal neurons.
    Shah MM; Haylett DG
    J Neurophysiol; 2002 Jun; 87(6):2983-9. PubMed ID: 12037201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SK (KCa2) channels do not control somatic excitability in CA1 pyramidal neurons but can be activated by dendritic excitatory synapses and regulate their impact.
    Gu N; Hu H; Vervaeke K; Storm JF
    J Neurophysiol; 2008 Nov; 100(5):2589-604. PubMed ID: 18684909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking SK channels impairs long-term memory formation in young chicks.
    Baker KD; Edwards TM; Rickard NS
    Behav Brain Res; 2011 Jan; 216(1):458-62. PubMed ID: 20678527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SK Ca2+-activated K+ channel ligands alter the firing pattern of dopamine-containing neurons in vivo.
    Ji H; Shepard PD
    Neuroscience; 2006 Jun; 140(2):623-33. PubMed ID: 16564639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. K+ channel blockers: novel tools to inhibit T cell activation leading to specific immunosuppression.
    Panyi G; Possani LD; Rodríguez de la Vega RC; Gáspár R; Varga Z
    Curr Pharm Des; 2006; 12(18):2199-220. PubMed ID: 16787250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.